Maynards Europe Launches Private Treaty Sale for Former Veranova API Manufacturing Site in Annan
Maynards Europe has announced the launch of a major private treaty sale offering the complete contents of a modern (Active Pharmaceutical Ingredient) API manufacturing facility. Formerly operated by Veranova, the Annan-based site in the UK is now available for immediate sale, presenting a rare opportunity for buyers to acquire high-specification pharmaceutical processing and lab equipment.
The private treaty sale runs until 30 September 2025, and includes the full manufacturing halls, labs, site support infrastructure, and spare parts inventory. Interested parties can schedule inspections by appointment only.
Key Assets Available for Sale:
- Hastalloy reactors, up to 9,000L
- Hastalloy hydrogenator, 1,000L
- Hastalloy pressure filters/driers
- GLMS reactors, up to 9,000L
- GLMS agitate receivers, up to 7,000L
- GLMS receiver, 1,000L
- Stainless steel agitate receivers, up to 12,000L
- Stainless steel Rosemund pressure filters, up to 7m²
- Stainless steel Buss horizontal vacuum driers
This sale presents a unique opportunity for pharmaceutical and chemical manufacturers to acquire premium-grade processing equipment from a well-maintained and modern API plant. Whether you’re looking to expand capacity or upgrade operations, these assets offer immediate operational value.
Maynards Europe is a leading global auctioneer and asset liquidation specialist with decades of experience across a wide range of industrial sectors. Known for managing large-scale sales of manufacturing and production equipment, Maynards delivers turnkey solutions for asset disposition, valuation, and recovery—serving clients in the pharmaceutical, automotive, electronics, and heavy industry markets worldwide.
For more information about this sale, please visit: